Ovarian Clear Cell Carcinoma: Genomic Characterization, Pathogenesis and Targeted Therapy.
Xie Y, Kong W, Luo D, Chen S, Zhao X, Zhang HE.
Anticancer Res. 2023 Aug;43(8):3401-3410. doi: 10.21873/anticanres.16515.
Ovarian clear cell carcinoma: open questions on the management and treatment algorithm.
Rosso R, Turinetto M, Borella F, Chopin N, Meeus P, Lainè A, Ray-Coquard I, Le Saux O, Ferraioli D.
Oncologist. 2025 Jan 17;30(1):oyae325. doi: 10.1093/oncolo/oyae325.
New therapies for clear cell ovarian carcinoma.
Stewart J, Cunningham N, Banerjee S.
Int J Gynecol Cancer. 2023 Mar 6;33(3):385-393. doi: 10.1136/ijgc-2022-003704.
Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes.
Gadducci A, Multinu F, Cosio S, Carinelli S, Ghioni M, Aletti GD.
Gynecol Oncol. 2021 Sep;162(3):741-750. doi: 10.1016/j.ygyno.2021.06.033. Epub 2021 Jul 8.
Ovarian Clear Cell Carcinoma: An Endometriosis-Associated Cancer with Therapeutic Challenges.
Huang RY, Lin JJ.
Cold Spring Harb Perspect Med. 2025 Aug 1;15(8):a041315. doi: 10.1101/cshperspect.a041315.
Translational genomics of ovarian clear cell carcinoma.
Khalique S, Lord CJ, Banerjee S, Natrajan R.
Semin Cancer Biol. 2020 Apr;61:121-131. doi: 10.1016/j.semcancer.2019.10.025. Epub 2019 Nov 4.
Precision medicine for ovarian clear cell carcinoma based on gene alterations.
Kuroda T, Kohno T.
Int J Clin Oncol. 2020 Mar;25(3):419-424. doi: 10.1007/s10147-020-01622-z. Epub 2020 Feb 4.
Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1alpha and tumor progression of clear cell ovarian cancer.
Mori Y, Okimoto Y, Sakai H, Kanda Y, Ohata H, Shiokawa D, Suzuki M, Yoshida H, Ueda H, Sekizuka T, Tamura R, Yamawaki K, Ishiguro T, Mateos RN, Shiraishi Y, Yatabe Y, Hamada A, Yoshihara K, Enomoto T, Okamoto K.
Cell Rep Med. 2024 May 21;5(5):101532. doi: 10.1016/j.xcrm.2024.101532. Epub 2024 Apr 25.
Molecular pathogenesis of ovarian clear cell carcinoma.
Gounaris I, Brenton JD.
Future Oncol. 2015;11(9):1389-405. doi: 10.2217/fon.15.45.
The immunotherapy era in ovarian clear cell carcinoma: current evidence and future perspective.
Passarelli A, Cecere SC, Ventriglia J, Pisano C, De Cecio R, Rossetti S, Tambaro R, Di Napoli M, Lobianco L, Calvanese G, Lamia MR, Perri E, Peluso MS, Scarpa E, Stilo S, Fiore F, Setola SV, Califano D, Pignata S.
Front Immunol. 2025 Nov 26;16:1661048. doi: 10.3389/fimmu.2025.1661048. eCollection 2025.
